Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LYMPHOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04824950
What this trial is testing

Circulating Tumor DNA in Primary Mediastinal Large B-cell Lymphoma (PMBL)

Who this might be right for
Primary Mediastinal Large B-cell Lymphoma
Centre Henri Becquerel 87
Testing effectiveness (Phase 2)Ended earlyNCT05272813
What this trial is testing

Investigate the Efficacy and Safety of MS-553 in CLL/SLL

Who this might be right for
Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. 13
Early research (Phase 1)Study completedNCT00586703
What this trial is testing

Safety Trial of NK Cell DLI 3-5/6 Family Member Following Nonmyeloablative ASCT

Who this might be right for
Lymphoma
David Rizzieri, MD 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03610438
What this trial is testing

Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 76
Not applicableLooking for participantsNCT06073938
What this trial is testing

Compassionate Use Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement

Who this might be right for
Advanced Solid Tumors or Lymphomas
Hunan Province Tumor Hospital 30
Large-scale testing (Phase 3)WithdrawnNCT00349518
What this trial is testing

Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphoblastic Leukemia
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT01611623
What this trial is testing

Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Solid Tumor Malignancies

Who this might be right for
Cancer
Esanex Inc. 9
Not applicableStudy completedNCT00440817
What this trial is testing

An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease.

Who this might be right for
Lymphoma
Centocor Ortho Biotech Services, L.L.C. 120
Large-scale testing (Phase 3)Study completedNCT01197560
What this trial is testing

Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma
Celgene 111
Not applicableStudy completedNCT06735482
What this trial is testing

Therapeutic Play in Children With Mild Intellectual Disability

Who this might be right for
Intellectual DisabilityIntellectual Disability, MildMotor and Developmental Delay+3 more
Beni-Suef University 20
Not applicableStudy completedNCT05886478
What this trial is testing

A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab Vedotin

Who this might be right for
T-Cell Lymphoma
Takeda 26
Early research (Phase 1)Study completedNCT01388335
What this trial is testing

A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin

Who this might be right for
Solid TumorLymphoma, Malignant
Eli Lilly and Company 13
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Not applicableNot Yet RecruitingNCT06050850
What this trial is testing

Healthy Weight Intervention Families During ALL Treatment: NOURISH-ALL

Who this might be right for
ALL, ChildhoodBehavior, Health
University of Kansas Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00074191
What this trial is testing

Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma

Who this might be right for
Lymphoma
OHSU Knight Cancer Institute 1
Large-scale testing (Phase 3)Active Not RecruitingNCT06569420
What this trial is testing

Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC

Who this might be right for
Non-Small Cell Lung CancerALK-positiveSAF-189s
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 275
Early research (Phase 1)Looking for participantsNCT05963217
What this trial is testing

Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLL

Who this might be right for
Relapsed or Refractory CD19+ B-cell LymphomaRelapsed or Refractory Chronic Lymphocytic LeukemiaRelapsed or Refractory Small Lymphocytic Lymphoma
University Health Network, Toronto 19
Not applicableLooking for participantsNCT06678282
What this trial is testing

JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia

Who this might be right for
B-NHLB-ALL
Shenzhen Genocury Biotech Co., Ltd. 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07724782
What this trial is testing

Multi-Cohort Study of Zeprumetostat Combinations for Relapsed/Refractory PTCL

Who this might be right for
PTCL-NOS
Tianjin Medical University Cancer Institute and Hospital 33
Early research (Phase 1)Study completedNCT00674024
What this trial is testing

Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function

Who this might be right for
NeoplasmsLymphoma
National Cancer Institute (NCI) 8
Next Page